Intermittent fasting—the future treatment in NASH patients?

I Minciuna, S Gallage, M Heikenwalder… - Hepatology, 2023 - journals.lww.com
NASH is one of the leading causes of chronic liver disease with the potential of evolving
towards end-stage liver disease and HCC, even in the absence of cirrhosis. Apart from …
被引用次数：9 相关文章

Intermittent fasting-the future treatment in nash patients?

I Minciună, S Gallage, M Heikenwalder, S Zelber-Sagi… - Hepatology - journals.lww.com
Non-alcoholic steatohepatitis (NASH) is one of the leading causes of chronic liver disease
with the potential of evolving towards end-stage liver disease and hepatocellular carcinoma …

Intermittent fasting—the future treatment in NASH patients?

I Minciuna, S Gallage, M Heikenwalder, S Zelber-Sagi… - Hepatology, 2023 - cir.nii.ac.jp
抄録< jats: p> NASH is one of the leading causes of chronic liver disease with the potential
of evolving towards end-stage liver disease and HCC, even in the absence of cirrhosis …

Intermittent fasting-the future treatment in NASH patients?

I Minciuna, S Gallage… - Hepatology …, 2023 - pubmed.ncbi.nlm.nih.gov
NASH is one of the leading causes of chronic liver disease with the potential of evolving
towards end-stage liver disease and HCC, even in the absence of cirrhosis. Apart from …

Intermittent fasting-the future treatment in nash patients?

I Minciună, S Gallage, M Heikenwalder… - Hepatology …, 2023 - europepmc.org
Non-alcoholic steatohepatitis (NASH) is one of the leading causes of chronic liver disease
with the potential of evolving towards end-stage liver disease and hepatocellular carcinoma …

Intermittent fasting—the future treatment in NASH patients?

I Minciuna, S Gallage, M Heikenwalder… - …, 2023 - ingentaconnect.com
NASH is one of the leading causes of chronic liver disease with the potential of evolving
towards end-stage liver disease and HCC, even in the absence of cirrhosis. Apart from …